| Long name: |
BARD1 Antibody |
| Antigen: |
BARD1 |
| Other names: |
BRCA1 associated RING domain 1, BRCA1-associated RING domain gene 1, BRCA1-associated RING domain protein 1, BRCA1-associated RING domain protein 1, N/A, mRNA, Homo sapiens BRCA1 associated RING domain 1 |
| Gene name: |
BARD1, BARD1 |
| Gene synonims: |
BARD-1, BARD1, BARD1 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Human (Homo sapiens) |
| Specificity: |
BARD1, This is an antibody designed to detect BARD1 |
| Purification method: |
Antigen Affinity method, Caprylic Acid Ammonium Sulfate Precipitation, etc, The most common purification methods used in the antibody production are Affinity Chromatography |
| Form/Appearance: |
02% NaN3, BARD1 antibody purified by protein affinity column containing 1% BSA and 0 |
| Concentration: |
100ug/200ul |
| Storage, shipping and handling: |
Avoid repeated freeze/defrost cycles, The antibody is stable for at least one year when stored at -20 degree C after reconstitution, Already reconstituted in 200ul sterile H2O |
| Applications: |
EIA, ELI-Spot, IFA, Immunohistochemistry (IHC), Western Blot (WB), ELISA |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
BARD1 |
| Short name: |
Anti- BARD1 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
early onset associated RING domain 1 (Antibody to), Antibody to breast cancer 1 |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BARD1 and IDBG-643630 and ENSBTAG00000033690 and 530961, BARD1 and IDBG-80113 and ENSG00000138376 and 580, Bard1 and IDBG-164443 and ENSMUSG00000026196 and 12021, nuclei, protein heterodimerization activity, this GO :0000151 and ubiquitin ligase complex and cellular component this GO :0001894 and tissue homeostasis and biological process this GO :0003723 and RNA binding and molecular function this GO :0004842 and ubiquitin-protein transferase activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005730 and nucleolus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0006281 and DNA repair and biological process this GO :0006974 and cellular response to DNA damage stimulus and biological process this GO :0007050 and cell cycle arrest and biological process this GO :0008270 and zinc ion binding and molecular function this GO :0016567 and protein ubiquitination and biological process this GO :0016874 and ligase activity and molecular function this GO :0019900 and kinase binding and molecular function this GO :0031436 and BRCA1-BARD1 complex and cellular component this GO :0031441 and negative regulation of mRNA 3'-end processing and biological process this GO :0042325 and regulation of phosphorylation and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043231 and intracellular membrane-bounded organelle and cellular component this GO :0045732 and positive regulation of protein catabolic process and biological process this GO :0046826 and negative regulation of protein export from nucleus and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0070531 and BRCA1-A complex and cellular component this GO :0085020 and protein K6-linked ubiquitination and biological process, this GO :0003723 : RNA binding, this GO :0003723 : RNA binding and also this GO :0004842 : ubiquitin-protein transferase activity and also this GO :0005515 : protein binding and also this GO :0008270 : zinc ion binding and also this GO :0016874 : ligase activity and also this GO :0019900 : kinase binding and also this GO :0042803 : protein homodimerization activity and also this GO :0046982 : protein heterodimerization activity, this GO :0004842 : ubiquitin-protein transferase activity, this GO :0005515 : protein binding, this GO :0008270 : zinc ion binding, this GO :0016874 : ligase activity, this GO :0019900 : kinase binding, this GO :0042803 : protein homodimerization activity, this GO :0046982 : protein heterodimerization activity, BRCA1 associated RING domain 1 |
| Identity: |
952 |
| Gene: |
BARD1 |
More about : BARD1 |
| Long gene name: |
BRCA1 associated RING domain 1 |
| Locus: |
2q35 |
| Discovery year: |
1998-08-05 |
| Entrez gene record: |
580 |
| Pubmed identfication: |
8944023 9425226 15159397 |
| RefSeq identity: |
NM_000465 |
| Classification: |
Ankyrin repeat domain containing BRCA1 B complex |
| Havana BLAST/BLAT: |
OTTHUMG00000133016 |